About CannaPharmaRx
CannaPharmaRx is a company based in Irvine (United States) founded in 1998.. The company has 26 employees as of December 31, 2024. CannaPharmaRx has completed 2 acquisitions, including Alternative Medical Solutions and LTB Management. CannaPharmaRx offers products and services including Medical Cannabis, Craft Products, and CBD Oil. CannaPharmaRx operates in a competitive market with competitors including American Cannabis Company, KushCo Holdings, Kush Supply, NewBridge Global Ventures and KAYA Holdings, among others.
- Headquarter Irvine, United States
- Employees 26 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Cannapharmarx Inc.
-
Annual Revenue
$820.14 K0as on Dec 31, 2024
-
Net Profit
$-9.91 M-368.56as on Dec 31, 2024
-
EBITDA
$-3.61 M-149.1as on Dec 31, 2024
-
Latest Funding Round
- Investors
-
Employee Count
26
as on Dec 31, 2024
-
Investments & Acquisitions
Alternative Medical Solutions
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of CannaPharmaRx
CannaPharmaRx is a publicly listed company on the OTC with ticker symbol CPMD in USA, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of CannaPharmaRx
CannaPharmaRx offers a comprehensive portfolio of products and services, including Medical Cannabis, Craft Products, and CBD Oil. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Customizable strains for medical use and treatment.
High-quality small-batch cannabis rich in terpenes.
Derived CBD oil for health and therapeutic applications.
Funding Insights of CannaPharmaRx
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(03 Jun 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Post-IPO - CannaPharmaRx | Valuation |
investors |
|
| Mar, 2019 | Amount | Post-IPO - CannaPharmaRx | Valuation |
investors |
|
| Jan, 2019 | Amount | Post-IPO - CannaPharmaRx | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CannaPharmaRx
CannaPharmaRx has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TRITON FUNDS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment opportunities in various sectors are provided by Triton Funds.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CannaPharmaRx
CannaPharmaRx has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Alternative Medical Solutions and LTB Management. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
E-commerce financial platform services are provided to support online sales.
|
2019 | ||||
|
Medical cannabis products are cultivated and produced in Canada.
|
0 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CannaPharmaRx
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cannapharmarx Comparisons
Competitors of CannaPharmaRx
CannaPharmaRx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as American Cannabis Company, KushCo Holdings, Kush Supply, NewBridge Global Ventures and KAYA Holdings, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Manufacturer of cannabis products
|
|
| domain | founded_year | HQ Location |
Developer, manufacturer and distributor of products and services
|
|
| domain | founded_year | HQ Location |
Wholesaler of vaporizer products, cannabis packaging, and dispensary supplies
|
|
| domain | founded_year | HQ Location |
Cannabis-based products are manufactured by NewBridge Global Ventures.
|
|
| domain | founded_year | HQ Location |
Cannabis products are produced and distributed by KAYA Holdings.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cannapharmarx
Frequently Asked Questions about CannaPharmaRx
When was CannaPharmaRx founded?
CannaPharmaRx was founded in 1998 and raised its 1st funding round 16 years after it was founded.
Where is CannaPharmaRx located?
CannaPharmaRx is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
How many employees does CannaPharmaRx have?
As of Dec 31, 2024, the latest employee count at CannaPharmaRx is 26.
What is the annual revenue of CannaPharmaRx?
Annual revenue of CannaPharmaRx is $820.14K as on Dec 31, 2024.
What does CannaPharmaRx do?
CannaPharmaRx was established in 1998 in Irvine, United States, within the medical cannabis sector. Operations are centered on the development, distribution, and regulatory compliance of cannabis-based pharmaceuticals. Services encompass product formulation for therapeutic applications and supply chain management for healthcare providers. Focus is maintained on legal standards and market access in the domestic pharmaceutical landscape.
Who are the top competitors of CannaPharmaRx?
CannaPharmaRx's top competitors include KushCo Holdings, NewBridge Global Ventures and American Cannabis Company.
What products or services does CannaPharmaRx offer?
CannaPharmaRx offers Medical Cannabis, Craft Products, and CBD Oil.
Is CannaPharmaRx publicly traded?
Yes, CannaPharmaRx is publicly traded on OTC under the ticker symbol CPMD.
How many acquisitions has CannaPharmaRx made?
CannaPharmaRx has made 2 acquisitions, including Alternative Medical Solutions, and LTB Management.
Who are CannaPharmaRx's investors?
CannaPharmaRx has 1 investor. Key investors include TRITON FUNDS.
What is CannaPharmaRx's ticker symbol?
The ticker symbol of CannaPharmaRx is CPMD on OTC.